Rabson Mendenhall Syndrome with Medullary Nephrocalcinosis: A Novel Mutation Reported
Keywords:
Rabson Mendenhall Syndrome, Syndrome of insulin resistance, INSR gene mutationAbstract
Background: Rabson Mendenhall syndrome is a syndrome of insulin resistance. Case characteristics: Clinical features and labs of our patient favoured insulin resistance, genetic analysis done showed a compound heterozygous mutation in the INSR gene which has not been reported earlier. Outcome: We report a new mutation causing disease and medullary nephrocalcinosis association which has been reported only once. Message: Biguanides are effective in reducing hyperglycaemia in Rabson Mendenhall syndrome.
Downloads
References
Vidal-Puig A et al. 1997 Insulin resistance: Classification, prevalence, clinical manifestations, and diagnosis. In: Azziz R, Nestler JE Dewailly D, eds. Androgen excess disorders in women. Philadelphia: Lippincott Raven; 227-236.
Bergman RN. 1989 Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes. 38:1512-1527.
Bergman RN et al. 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 79:790-800.
Sarita Kumar et al. Case report of rabson Mendenhall syndrome. Indian J Med Sci Vol. 59 No. 2, February 2005
Alexandre A et al. Urinary calcium excretion and insulin resistance in patients with acromegaly International Urology and Nephrology 44(5): 1473-7, January 2012.
Baynes KCR et al. 1997 Molecular mechanisms of inherited insulin resistance. Q J Med. 90: 557-562.
Cochran E et al. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome .J. Clin. Endocr. Metab. 89: 1548-1554, 2004
Krook A et al. 1996 Functional activation of mutant human insulin receptor by monoclonal antibody. Lancet. 347:1586-1590.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.